KPTI- Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.78M | - | |
| VP | 79.5K | $715.6K | - | |
| VP | 67.4K | $606.5K | - | |
| VP | 65.1K | $585.7K | - | |
| VP | 56.3K | $506.6K | - |
Activity
Buys and sells only
Transactions
10 filings · page 17
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2020 | Shacham Sharon79 | President &CSO | Sell | 17,634 | $16.48 | $290,641.82 | -1.3% | |
| Feb 19, 2020 | Kauffman Michael78 | Chief Executive Officer | Sell | 17,634 | $16.48 | $290,641.82 | -1.3% | |
| Feb 11, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 20,000 | $17.18 | $343,621.00 | -1.5% | |
| Feb 11, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 20,000 | $17.18 | $343,621.00 | -1.5% | |
| Jan 9, 2020 | Mirza Mansoor Raza79 | Director | Sale+OE | 2,056 | $20.00 | $41,120.00 | -100% | |
| Jan 9, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 20,000 | $18.88 | $377,585.00 | -1.5% | |
| Jan 9, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 20,000 | $18.88 | $377,585.00 | -1.5% | |
| Dec 27, 2019 | Primiano Christopher Brett | EVP, Cbo, GC &Secretary | Sale+OE | 5,000 | $20.00 | $100,000.00 | -57.8% | |
| Dec 27, 2019 | Mirza Mansoor Raza79 | Director | Sale+OE | 2,944 | $20.00 | $58,880.00 | -100% | |
| Dec 18, 2019 | Mirza Mansoor Raza79 | Director | Sale+OE | 12,121 | $17.18 | $208,235.69 | -63.0% |